| Record ID | marc_loc_updates/v35.i23.records.utf8:17435132:1896 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_updates/v35.i23.records.utf8:17435132:1896?format=raw |
LEADER: 01896cam a22003258a 4500
001 2007017891
003 DLC
005 20070601073546.0
008 070427s2007 nju b 001 0 eng
010 $a 2007017891
020 $a9780471752158 (cloth)
035 $a(DNLM)101305787
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRS420$b.A79 2007
060 10 $aQV 744$bA784 2007
082 00 $a615/.19$222
245 04 $aThe art of drug synthesis /$cedited by Douglas S. Johnson and Jie Jack Li.
260 $aHoboken, N.J. :$bJohn Wiley & Sons,$cc2007.
263 $a0706
300 $ap. ;$ccm.
504 $aIncludes bibliographical references and index.
505 0 $aThe role of mechanical chemistry in drug discovery -- Process research: how much? how soon? -- Aromatase inhibitors for breast cancer -- Quinolone antibiotics -- Triazole antifungals -- Non-nucleoside HIV reverse transcription inhibitors -- Neuraminidase inhibitors for influenza -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes -- Angiotensin AT1 antagonists for hypertension -- Leading ACE inhibitors for hypertension -- Dihydropyridine calcium channel blockers for hypertension -- 2nd generation HMG-CoA reductase inhibitors -- Cholesterol absorption inhibitors: ezetimibe (zetia) -- Dual service serotonin and norepinephrine reuptake inhibitors (SSNRI) for depression -- Gaba receptor agonists for insomnia -- Ligands: neurontin? (gabapentin) and lyrica? (pregabalin) -- Approved treatments for attention deficit hyperactivity disorder (ADHD).
650 0 $aDrugs$xDesign.
650 0 $aPharmaceutical chemistry.
650 12 $aDrug Design.
650 22 $aChemistry, Pharmaceutical$xmethods.
700 1 $aJohnson, Douglas S.$q(Douglas Scott),$d1968-
700 1 $aLi, Jie Jack.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0717/2007017891.html